Advertisement

Die infektiöse Urethritis des Mannes

  • W. Krause
  • W. Weidner

Zusammenfassung

Die männliche infektiöse Urethritis ist die häufigste der sexuell übertragbaren Krankheiten. Als meist verantwortliche Erreger kennt man N. gonorrhoeae, C. trachomatis und U. urealyticum, dagegen sind T. vaginalis, Herpesvirus hominis, C. albicans und Enterobakterien ausgesprochen selten. Die klinischen Erscheinungen erlauben keine Differentialdiagnose, sondern diese muß durch spezifische mikrobiologische Techniken gestellt werden. In der Therapie, die sich natürlich nach der Art des Erregers richtet, ist Tetracyclin meist erfolgreich, da die drei genannten häufigen Erreger hierauf ansprechen. Die Prognose ist trotz hoher Spontanheilungsrate durch aufsteigende Infektionen belastet.

Summary

The male infectious urethritis is the most frequent sexually transmitted disease. The common etiologic agents are N. gonorrhoeae, C. trachomatis and U. urealyticum, while T. vaginalis, herpesvirus hominis, C. albicans and enterobacteria are seldom found. The clinical appearance is not characteristic for any of the microorganisms, but these have to be isolated by different and specific techniques. Treatment with tetracycline is often successful, as the three common bacteria species are sensitive against this agent. The prognosis is good, but besides a high rate of spontaneous cure ascendent infections of the prostate gland and other male adnexe occur.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Al-Egaily, S, Dunlop, E M, Rodin, P, Seth, A D.: Thalampicillin and probenicid compared with ampicillin and probenicid for the treatment of gonococcal urethritis in men. Brit. J. vener. Dis. 54, 243–246 (1978).Google Scholar
  2. 2.
    Aluoch, JA, Olel-Odhiambo.: Simple clinical evaluation of cephalexin in the treatment of uncomplicated gonococcal urethritis in males. East Afr. med. J. 55, 519–522 (1978).PubMedGoogle Scholar
  3. 3.
    Arnold, A J, Kleris, G S.: The ‘borderline’ smear in men with urethritis. JAMA 244, 157–159 (1980).PubMedGoogle Scholar
  4. 4.
    Arum, E S, Jacobs, N F.: Nonogonococcal urethritis. Cutis 17: 719–722 (1976).PubMedGoogle Scholar
  5. 5.
    Arya, O P, Alergant, C D, Annels, E H, Carey, P B, Gosh, A K, Goddard, A D.: Management of non-specific urethritis in men. Evaluation of six treatment regimens and effect of other factors including alcohol and sexual intercourse. Brit. J. vener. Dis. 54, 414–421 (1978).Google Scholar
  6. 6.
    Arya, O P, Alergant, C D, Annels, E H, Carey, P B, Gosh, A K, Goddard, A D: Management of non-specific urethritis in men (letter). Brit. J. vener. Dis. 56, 117 (1980).Google Scholar
  7. 7.
    Bakar, R, Lim, V K.: Single-dose oral ampicillin in the treatment of gonococcal urethritis in males. Med. J. Malaysia 36, 202–204 (1981).PubMedGoogle Scholar
  8. 8.
    Baskin, M N, Fiumara, N J, Hayes, M.: Treatment of urethritis in men with minocyclin, abstract N° 431. 11th Intern. Congr. Chemoth., Boston (1979).Google Scholar
  9. 9.
    Berg, S W, Kilpatrick, M E, Harrison, W O, McCutchan, JA.: Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae. New Engl. J. Med. 301, 509–511 (1979).PubMedGoogle Scholar
  10. 10.
    Bergner, M.: Vergleichende Untersuchungen mit verschiedenen Testsystemen zum Nachweis des Erregers N. gonorrhoeae. Z. Hautkr. 56, 1054–1065 (1981).Google Scholar
  11. 11.
    Bjornberg, A, Hellgren, L.: Minocycline in gonorrhoeic and non-gonorrhoeic urethritis. Curr. Ther. Res. 19, 216–219 (1976).PubMedGoogle Scholar
  12. 12.
    Blenk, H.: Diagnostik und Therapie der nichtgonorrhoischen Genitalinfektion. Urologe B 19, 278–285 (1979).Google Scholar
  13. 13.
    Blenk, H, Wichmann, G, Rhode, B T, Braun, B.: Vorkommen von Mycoplasmen in der Harnröhre von gesunden Männern. Münch, med. Wschr. 117, 1029 (1975).Google Scholar
  14. 14.
    Blenk, H, Blenk, B, Deimann, E.: Erythromycin treatment of acute and chronic urethritis, prostatitis and colpitis caused by Ureaplasma urealyticum and chlamydia trachomatis. J. int. med. Res. 8, 59–63 (1980).PubMedGoogle Scholar
  15. 15.
    Blockhart, M.: Über die pseudo-gonorrhoische Entzündung der Harnröhre und des Nebenhodens. Mschr. prakt. Derm. 5, 134–156 (1886).Google Scholar
  16. 16.
    Bowie, W R.: Comparison of gram stain and first voided wine sediment in the diagnosis of urethritis. Sex. transm. Dis. 5, 39 (1978).PubMedGoogle Scholar
  17. 17.
    Bowie, W R, Yu, J S, Fawcett, A P.: Tetracycline (TCN) for non-gonococcal urethritis. 11th Intern. Congr. Chemoth., Boston, Abstr. 480 (1979).Google Scholar
  18. 18.
    Bowie, W R, Yu, J S, Fawcett, A, Jones, H D.: Tetracycline in nongonococcal urethritis. Comparison of 2 g and 1 g daily for seven days. Brit. J. vener. Dis. 56, 332–336 (1980).Google Scholar
  19. 19.
    Bowie, WR, Alexander, R E, Holmes, K K: Eradication of chlamydia trachomatis from the urethras of men with nongonococcal urethritis by treatment with amoxicillin. Sex. transmitt. Dis. 8, 79–81 (1981).Google Scholar
  20. 20.
    Bowie, WR, Alexander, E R, Stimson, J B, Floyd, J F, Holmes, K K.: Therapy for nongonococcal urethritis: double-blind randomized comparison of two doses and two durations of minocycline. Ann. intern. Med. 95, 306–311 (1981).PubMedGoogle Scholar
  21. 21.
    Brade, H, Brunner, H, Stute, R.: Über das Vorkommen komplementbindender Antikörper gegen Chlamydien in der Bevölkerung. Immun, u. Infekt. 7, 30–33 (1979).Google Scholar
  22. 22.
    Braff, E H, Wibbelsman, C J.: Asymptomatic gonococcal urethritis in selected males. Amer. J. publ. Hlth 68, 779–780 (1978).Google Scholar
  23. 23.
    Bredt, W.: Diagnostik der infektiösen nicht-gonorrhoischen Urethritis. Dtsch. med. Wschr. 106, 909–911 (1981).PubMedGoogle Scholar
  24. 24.
    Bruce, A W, Chadwick, P, Willett, WS.: The role of chlamydia in genitourinary disease. J. Urol. (Baltimore) 126, 625–629 (1981).Google Scholar
  25. 25.
    Brunnberg, F J.: Gonorrhoe und Spectinomycin: Grundlagen. Z. Hautkr. 52, 1–3 (1976).Google Scholar
  26. 26.
    Brunner, H, Weidner, W.: Die akute Urethritis-eine Übersicht. Münch, med. Wschr. 120, 1586–1587 (1978).Google Scholar
  27. 27.
    Bygdeman, S, Danielsson, D, Sandström, E.: Serological classification of Neisseria gonorrhoeae by coagglutination: a study of serological patterns in two geographical areas of Sweden. Acta derm.-vener. (Stockh.) 61, 423–427 (1981).Google Scholar
  28. 28.
    Calin, A.: HLA-B27: To type of not to type? Ann. intern. Med. 92, 208–211 (1980).PubMedGoogle Scholar
  29. 29.
    Cevenini, R, Placa, M La.: Chlamydial infections in Italy. Sex. trasmitt. Dis. 8, 349–352 (1981).Google Scholar
  30. 30.
    Danielsson, D, Wikström, K.: Diagnostic aspects of gonococcal and non-gonococcal urethritis results of treatment with trimethoprim-sulphamethoxazole, p. p. 299–305 (1974). In: Danielsson, D. et al. (Eds.). Genital infections and their complications. Stockholm, Almqvist & Wiksell.Google Scholar
  31. 31.
    Dame, J F, Ridgway, G L, Oriel, J D.: Rosaramicin and tetracycline in the treatment of non-gonococcal urethritis. A comparison of clinical and microbiological results. Brit. J. vener. Dis. 58, 117–120 (1982).Google Scholar
  32. 32.
    Davis, B D, Dulbecco, R, Eisen, H N, Ginsberg, H S.: Microbiology, 3rd. Ed. Harper Intern, Philadelphia (1980).Google Scholar
  33. 33.
    Desai, K, Robson, H G.: Comparison of the gram-stained urethral smear and first-voided urine sediment in the diagnosis of non-gonococcal urethritis. Sex. transmitt. Dis. 9, 21–25 (1982).Google Scholar
  34. 34.
    Drach, G W, Kohnen, P W.: Prostatitis. In: Urologie Pathology, M. Tannenbaum (Ed.), Philadelphia (1977).Google Scholar
  35. 35.
    Eichmann, A, Weidmann, G, Havas, L.: One-dose treatment of acute uncomplicated gonorrhoea of male patients with ceftriaxone Ro 13–9904, a new parenteral cephalosporin. A dose-range finding pilot study using doses of 500, 250, 125 and 50 mg respectively, in descending order. Chemotherapy 27, 62–69 (1981).PubMedGoogle Scholar
  36. 36.
    Evans, B A.: Treatment and prognosis of non-specific genital infection. Brit. J. vener. Dis. 54, 107–111, (1978).Google Scholar
  37. 37.
    Evans, B.: Management of non-specific urethritis in men (letter). Brit. J. vener. Dis. 55, 305, (1979).Google Scholar
  38. 38.
    Gale, J L, Hinds, M W.: Male urethritis in king county, Washington, 1974–75: I. Incidence. Amer. J. publ. Hlth 68, 20–25 (1978).Google Scholar
  39. 39.
    Gilbaugh, J H, Fuchs, P C; The gonococcus and the toilet seat. New Engl. J. Med. 301, 91 (1979).PubMedGoogle Scholar
  40. 40.
    Grimble, A S, Amarasuriya, K L.: Non-specific urethritis and the tetracyclines. Brit. J. vener. Dis. 51, 198–205 (1975).Google Scholar
  41. 41.
    Handsfield, H H.: Nongonococcal urethritis. Cutis 27, 268–277 (1981).PubMedGoogle Scholar
  42. 42.
    Hard, S, Moberg, I, Wennberg, K.: Treatment of gonococcal urethritis in males with a single dose of cefotaxime (proceedings). J. antimicrob. Chemother. 6, 289 (1980).PubMedGoogle Scholar
  43. 43.
    Harrison, W O.: Cefaclor in the treatment of uncomplicated gonococcal urethritis. Postgrad, med. J. 55, 85–87 (1979).Google Scholar
  44. 44.
    Helmy, N, Fowler, W.: Intensive and prolonged tetracycline therapy in non-specific urethritis. Brit. J. vener. Dis. 51, 336–339 (1975).Google Scholar
  45. 45.
    Heywood, C P, Bacon, P M.: Social background and diagnosis. Survey of male clinic registrations. Brit. J. vener. Dis. 51, 405–409Google Scholar
  46. 46.
    Hofstetter, A, Vogt, HJ.: Mycoplasmen. Folia ichthyol. 19 (1976).Google Scholar
  47. 47.
    Hofstetter, A, Blenk, H, Rangoonwala, R.: Tetrazykline zur Behandlung der Mykoplasmen-Prostato-Urethritis. Münch, med. Wschr. 118, 49–50 (1976).Google Scholar
  48. 48.
    Hofstetter, A, Blenk, H, Meilin, H E, Rattenhuber, U, Schilling, A.: Behandlung von Chlamydien-Urethro-Adnexitiden mit Erythromycin. Fortschr. Med. 95, 2445–2448 (1977).PubMedGoogle Scholar
  49. 49.
    Hunton, R B, Harper, R G, Bremner, D A, Hookham, A B.: Acute gonococcal urethritis in males treated with a single oral dose of pivampicillin hydrochloride. N. Z. med. J. 80, 205–208 (1974).PubMedGoogle Scholar
  50. 50.
    Iskandar, I O, Naguib, F, El Gabry, K, Fanous, V: A comparative study of gentamicin, co-trimoxazole and trimethoprim-sulphametrol in acute gonorrheal urethritis. J. Egypt, med. Ass. 61, 489–495 (1978).Google Scholar
  51. 51.
    Jaffe, H W, Schroeter, A L, Reynolds, G H, Zaidi, A A, Martin, J E, Thayer, J D.: Pharmacokinetic determinants of penicillin dure of gonococcal urethritis. Antimicrob. Agents Chemother. 15, 587–591 (1979).PubMedGoogle Scholar
  52. 52.
    Johannisson, G.: Studies on chlamydia trachomatis as a cause of lower urogenital tract infections. 56 pp. Department of Dermatology and Virology, University of Göteborg, Göteborg, Sweden. (1981).Google Scholar
  53. 53.
    Judson, FN.: Gonococcal urethritis-diagnosis and treatment. Arch. Androl. 3, 329–335 (1979).PubMedGoogle Scholar
  54. 54.
    Juvakoski, T, Allgulander, C, Lassus, A.: Rosaramicin and tetracycline treatment in Chlamydia trachomatis-positive and -negative nongonococcal urethritis. Sex. transmitt. Dis. 8, 12–15 (1981).Google Scholar
  55. 55.
    Juvakoski, T, Lauharanta, J, Kanerva, L, Lassus, A.: One-week treatment of chlamydia-positive urethritis with doxycycline and tetracycline chloride in males. Acta derm.-vener. (Stockh.) 61, 273–275 (1981).Google Scholar
  56. 56.
    Kogan, B A.: Nongonococcal urethritis. Urology 17: 219–222 (1981).PubMedGoogle Scholar
  57. 57.
    Konietzko, D.: Gonokokkenkultur in der Praxis. Dermatologe 27, 505–509 (1979).Google Scholar
  58. 58.
    Konrad, K: Paraurethritis gonorrhoica als Ursache für ein Gonorrhoe-Rezidiv. Z. Hautkr. 51, 433–436, (1976)Google Scholar
  59. 59.
    Kraus, S J.: Semiquantitation of urethral polymorphonuclear leukocytes as objective evidence of nongonococcal urethritis. Sex. transmitt. Dis. 10, 52–55 (1982).Google Scholar
  60. 60.
    Landis, S J, Ramphai, R, Monsheim, B J, Rand, K H, Shands, J W: Comparative efficacy of piperacillin and penicillin G in treatment of gonococcal urethritis. Antimicrob. Agents Chemother. 20, 693–695 (1981).PubMedGoogle Scholar
  61. 61.
    Lassus, A, Paavonen, J, Kousa, M, Saikku, P.: Erythromycin and lymecycline treatment in chlamydia-positive and chlamydia-negative non-gonococcal urethritis. A partner-controlled study. Acta derm.-vener. (Stockh.) 59, 278–281 (1979).Google Scholar
  62. 62.
    Lee, Y H, Rosner, B, Albert, S, Fiumara, N J, MacCormack, W M.: Clinical and microbiological investigation of men with urethritis. J. infect. Dis. 138, 798–803 (1978).PubMedGoogle Scholar
  63. 63.
    Lewis, J S, Martin, J E.: Evaluation of the Phadebact Gonococcus test, a coagglutination procedure for confirmation of Neisseria gonorrhoeae. J. clin. Microbiol. 11, 153–156 (1980).PubMedGoogle Scholar
  64. 64.
    Mardh, PA, Martensson, D, Soltesz, L V: An effective, simplified medium for the culture of N. gonorrhoeae. Sex. transmitt. Dis. 5, 10–13 (1978).Google Scholar
  65. 65.
    Masterton, G, Schoßeid, C B S.: Minocyclin hydrochloride as a single dose oral treatment of uncomplicated gonorrhoea in men. Brit. J. vener. Dis. 52, 43–45 (1976).Google Scholar
  66. 66.
    Medebach, H, Kraushaar, J.: Kapseln sich Gonokokken ab? Z. Hautkr. 50, 157–160 (1975).PubMedGoogle Scholar
  67. 67.
    Melton, L J.: Comparative incidence of gonorrhoea and nongonococcal urethritis in the United States navy. Amer. J. Epidemiol. 104, 535–542 (1976).Google Scholar
  68. 68.
    Mertens, Th, Lanvers, A, Eggers, HJ.: Can herpesvirus hominis be isolated from the genito-urinary tract of men having no manifest symptoms of herpesvirus infection? 2. Tg. Chron. Prostatitis, Bad Nauheim, p. 17 Abstracts (1981).Google Scholar
  69. 69.
    Meyer-Röhn, J: Resistenzsituation von Neisseria gonorrhoeae gegenüber Spectinomycin. Z. Hautkr. 52, 7–8 (1976).Google Scholar
  70. 70.
    Munday, P E, Thomas, B J, Johnson, A P, Altman, D G, Taylor-Robinson, D.: Clinical and microbiological study of non-gonococcal urethritis with particular reference to non-chlamydial disease. Brit. J. vener. Dis. 57, 327–333 (1981).Google Scholar
  71. 71.
    Murray, E S, Benfari, M J, Coppola, S R, Hughes, M D, Feng, W C, Medeiros, R M, Kunz, L J.: New options for diagnosis and control of gonorrheal urethritis in males using uncentrifuges first voided urine (FVU) as a specimen for culture. Amer. J. publ. Hlth 69, 596–598 (1979).Google Scholar
  72. 72.
    Neubert, U, Ruckdeschel, G.: Zur Empfindlichkeit von N. gonorrhoeae gegenüber Spectinomycin. Hautarzt 32, 179–181 (1981).PubMedGoogle Scholar
  73. 73.
    Ngeow, Y F, Munday, P E, Evans, R T et al: Taking cell cultures to the patient in an attempt to improve chlamydial isolation. Brit. J. vener. Dis. 57, 44–46 (1981).Google Scholar
  74. 74.
    Normark, S, Elmroa, T, Norlander, L, Kjellberg, E, Holm, S, Burman, L A, Bergström, S.: Cefuroxime treatment of urethritis caused by a beta-lactamase-producing strain of Neisseria gonorrhoeae. Acta derm.-vener. (Stockh.) 60, 277–279 (1980).Google Scholar
  75. 75.
    Nwokolo, U.: Two gram single dose amoxycillin in treatment of gonococcal and other urethritides. Med. J. Zambia 9, 102–104 (1975).PubMedGoogle Scholar
  76. 76.
    Ongom, V L, Munafu, C, Mafigiri, J, Yiga, A.: Treatment of male gonococcal urethritis using pivampicillin (alphacillin) with or without probenecid. East Afr. Med. J. 54, 674–677 (1977).PubMedGoogle Scholar
  77. 77.
    Oriel, J D, Reeve, P, Wright, J T, Owen, J.: Chlamydial infection of the male urethra. Brit. J. vener. Dis. 52, 46 (1976).Google Scholar
  78. 78.
    Oriel, J D.: Treatment of nongonococcal urethritis, pp. 38–42 In: Hobson, D, Holmes, K K. (Eds.). Nongonococcal urethritis and related infections. Washington, American Society for microbiology. (1977).Google Scholar
  79. 79.
    Oriel, J D.: Management of nongonococcal urethritis. Drugs 18, 398–402 (1979).PubMedGoogle Scholar
  80. 80.
    Paavonen, J, Kousa, M, Saikku, P, Vartiainen, E, Kanerva, L, Lassus, A.: Treatment of nongonococcal urethritis with trimethoprim-sulphadiazine and with placebo. A double-blind partner-controlled study. Brit. J. vener. Dis. 56, 101–104 (1980).Google Scholar
  81. 81.
    Perera, P M.: Evaluation of a substained-release oral tetracycline in non-specific urethritis. Brit. J. vener. Dis. 51, 333–335 (1975).Google Scholar
  82. 82.
    Perroud, H M, Miedzybrodzka, K: Chlamydial infection of the urethra in men. Brit. J. vener. Dis. 54, 45–49 (1978).Google Scholar
  83. 83.
    Petzoldt, D.: Die Wirkung von Spectinomycin auf die Syphilis in der frühesten Inkubationsphase (tierexperimentelle Untersuchungen). Z. Hautkr. 52, 76–78 (1976).Google Scholar
  84. 84.
    Prentice, M J, Taylor-Robinson, D, Csonka, G W.: Non-specific urethritis. A placebo-controlled trial of minocycline in conjunction with laboratory investigations. Brit. J. vener. Dis. 52, 269–275 (1976).Google Scholar
  85. 85.
    Prior, R B, Spagna, V A.: Application of a limulus test device in rapid evaluation of gonococcal and nongonococcal urethritis in males. J. clin. Microbiol. 14, 256–260 (1981).PubMedGoogle Scholar
  86. 86.
    Quadripur, S A.: Infektiöse Urethritiden, Teil II. Med. Klin. 73, 1437–1441 (1978).Google Scholar
  87. 87.
    Raab, W.: Unerwünschte Wirkungen bei systemischer Antibiotikabehandlung unter besonderer Berücksichtigung von Spectinomycin. Z. Hautkr. 52, 9–14 (1976).Google Scholar
  88. 88.
    Rieth, H.: Hefe-Mykosen. Urban + Schwarzenberg, München-Berlin-Baltimore (1979).Google Scholar
  89. 89.
    Ripa, K T, Mardh, PA.: New simplified culture technique for C. trachomatis, p. 323–327 (1977). In: Hobson, D, Holmes, K K. (Eds.). Nongonococcal Urethritis, Amer. Soc. Microbiol.Google Scholar
  90. 90.
    Rodermund, O E.: Nicht-gonorrhoische Urethritis durch Trichomonas vaginalis. Münch, med. Wschr. 120, 1593 (1978).Google Scholar
  91. 91.
    Rodrigues, L G, Bird, B R, Kraus, S J.: Resources needed to culture Chlamydia trachomatis in laboratories of clinics for sexually transmitted diseases. Sex. transmitt. Dis. 9, 79–83 (1982).Google Scholar
  92. 92.
    Saeed, A, Roy. R B.: Evaluation & comparison of single dose oral treatment of uncomplicated gonococcal urethritis in males with talampidllin & minocycline. Brit. J. clin. Pract. 33, 199–201 (1979).PubMedGoogle Scholar
  93. 93.
    Schiefer, H G, Krauss, H.: Zellbiologie der Chlamydien. Labor. Med. 6, 51–53 (1982).Google Scholar
  94. 94.
    Schofield, C B, Masterton, G.: Doxyycline HCl (Vibramycin) syrup as a single-dose oral treatment for uncomplicated urethritis in men. Brit. J. vener. Dis. 50, 303–307 (1974).Google Scholar
  95. 95.
    Schofield, C B.: Some factors affecting the incubation period and duration of symptoms of urethritis in men. Brit. J. vener. Dis. 58, 184–188 (1982).Google Scholar
  96. 96.
    Smith, T F, Weed, L A, Pettersen, G R, O’Brien, P C.: A comparison of genital infections caused by Chlamydia trachomatis and by Neisseria gonorrhoeae. Amer. J. clin. Path. 70, 333–336 (1978).Google Scholar
  97. 97.
    Spagna, V A, Perkins, R L, Prior, R B.: Successful treatment with cefaclor of gonococcal urethritis in men. Sex. transmitt. Dis. 6, 211–213 (1979).Google Scholar
  98. 98.
    Stamm, WE, Holmes, K K: Treatment of urethritis with rosaramycin. Sex. transmitt. Dis. 29 (1980).Google Scholar
  99. 99.
    Swartz, S L, Kraus, S J, Herrmann, K, Stargel, M D, Brown, WJ, Allen, S D.: Diagnosis and etiology of nongonococcal urethritis. J. infect. Dis. 138, 445–454 (1978).PubMedGoogle Scholar
  100. 100.
    Szölts-Szöts, J.: Mikrobiell bedingte nichtgonorrhoische Urethritis. Diagnostik 8, 337–340 (1975).Google Scholar
  101. 101.
    Taylor-Robinson, D, Thomas, B J.: The role of C. trachomatis in genital tract and associated diseases. J. clin. Path. 33, 205–233 (1980).PubMedGoogle Scholar
  102. 102.
    Taylor-Robinson, D, Purcell, R H, London, W Tet ah: Microbiological, serological, and histopathological features of experimental Chlamydia trachomatis. Urethritis in chimpanzees. Brit. J. vener. Dis. 57, 36–40 (1981).Google Scholar
  103. 103.
    Terho, P.: Isolation techniques of C. trachomatis from patients with non-specific urethritis. Derm. Mschr. 164, 515–520 (1978).Google Scholar
  104. 104.
    Terho, P.: Chlamydia trachomatis in non-specific urethritis. Brit. J. vener. Dis. 54, 251 (1978).Google Scholar
  105. 105.
    Terho, P.: Treatment of chlamydia-positive and chlamydia-negative nonspecific and postgonococcal urethritis. Ann. clin. Res. 10, 299–302 (1978).PubMedGoogle Scholar
  106. 106.
    Thambar, I V, Simmons, P D, Thin, R N, Darougar, S, Yearsley, P.: Doubleblind comparison of two regimens in the treatment of nongonococcal urethritis. Seven-day vs 21-day course of triple tetracyclinic (detelco). Brit. J. vener. Dis. 55, 284–288 (1979).Google Scholar
  107. 107.
    Thayer, J D, Martin, J E.: A selective medium for the cultivation of N. gonorrhoeae and N. meningitidis. Publ. Hlth Rep. (Wash.) 79, 49–57 (1964).Google Scholar
  108. 108.
    Tubbs, H.: The management of penicillin resistant gonococcal urethritis in northern nigeria. J. trop. Med. Hyg. 82, 191–193 (1979).PubMedGoogle Scholar
  109. 109.
    Volk, J, Kraus, S J.: Nongonococcal urethritis. Arch. intern. Med. 134, 511–514 (1974).PubMedGoogle Scholar
  110. 110.
    Waterworth, P M, Oriel, J D, Ridgway, G L, Subra-Manian, S.: Single-dose minocycline in the treatment of gonococcal urethritis. Clinical efficacy in relation to bacterial resistance and its effects on associated chlamydia trachomatis infections. Brit. J. vener. Dis. 55, 343–347 (1979).Google Scholar
  111. 111.
    Waugh, MA, Cooke, E M, Nehaul, B B, Brayson, J.: Comparison of minocycline and ampicillin in gonococcal urethritis. Brit. J. vener. Dis. 55, 411–414 (1979).Google Scholar
  112. 112.
    Weidner, W, Brunner, H, Krause, W, Rothauge, C F.: Zur Bedeutung von U. urealytieum bei unspezifischer Prostatourethritis. Dtsch. med. Wschr. 103, 465–468 (1978).PubMedGoogle Scholar
  113. 113.
    Weidner, W, Schiefer, H G, Krauss, H, Engstfeld, J.: Untersuchungen zur Ätiologie der nicht-gonorrhoischen Urethritis. Dtsch. med. Wschr. 107, 1227–1231 (1982).PubMedGoogle Scholar
  114. 114.
    Weidner, W, Krause, W, Schiefer, H G, Krauss, H, Brunner, H: Prostatitis following non-gonococcal urethritis — a prospective study. 4th. Intern. Meet. Sex. Transm. Dis., Heidelberg 1981.Google Scholar
  115. 115.
    Welke, S.: Gonokokken-Nachweis durch mikrobiologischen Test. Diagnostik 11, 124–127 (1978).Google Scholar
  116. 116.
    Gonorrhea — CDC-recommended treatment schedules. J. infect. Dis. 139, 496–499 (1979).Google Scholar
  117. 117.
    Wiesner, P J.: Gonorrhea. Cutis 27, 249–254 (1981).Google Scholar
  118. 118.
    Wigand, R, Kümel, G.: Schnelle Diagnose von mucocutanem Herpes simplex durch Virusisolierung.Google Scholar
  119. 119.
    Wong, J L, Hines, P A, Brasher, M D, Rogers, G T, Smith, R F, Schachter, J.: The etiology of non-gonococcal urethritis in men attending a venereal disease clinic. Sex. transmitt. Dis. 4, 4–8 (1977).Google Scholar
  120. 120.
    Mardh, P-A, Bygdeman, S.: Susceptibility of thiamphenicol of Neisseria gonorrhoeae and certain other organisms causing genito-urinary, puerperal and neonatal infections. Intern. Symp. Thiamphenicol and Sexually Transm. Dis., Istanbul 1983.Google Scholar
  121. 121.
    Panikabutra, K, Ariyarit, C, Chitwarakorn, A, Saensanoh, C, Soonthararak, A.: Single dose treatment of uncomplicated gonorrhoeae in the male with 0.5 g thiamphenicol intramusculary and 2 g thiamphenicol orally. Intern. Symp. Thiamphenicol and Sexually Transm. Dis., Istanbul 1983.Google Scholar
  122. 122.
    Siboulet, A, Bohbot, J-M, Lhuillier, N, Siboulet, A, Catalan, F.: Minute treatment with thiamphenicol in 50,000 gonorrhoea. Intern. Symp. Thiamphenicol and Sexually Transm. Dis., Istanbul 1983.Google Scholar
  123. 123.
    Yunis, A A.: Differential in vitro toxicity of chloramphenicol, nitroso-chloramphenicol and thiamphenicol. Intern. Symp. Thiamphenicol and Sexually Transm. Dis., Istanbul 1983.Google Scholar
  124. 124.
    Buchmann, TM, Hildebrand, J F: Antigen-specific serotyping of Neisseria gonorrhoeae: characterization based upon principal outer membrane protein. Infect. Immun. 32, 985–994 (1981)Google Scholar
  125. 125.
    Hartmann, A A, Eisner, P: Gardnerella vaginalis-Infektion — eine weitere STD. Hautarzt 35, 512–516 (1984)PubMedGoogle Scholar
  126. 126.
    Knapp, J S, Tarn, M R, Nowinski, R C, Holmes, K K, Sandström, E G: Serological classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein I. J. infect. Dis. 150, 44–48 (1984)PubMedGoogle Scholar
  127. 127.
    Kohl, P K, Meyer, T F, Petzold, D: Gonokokkenoberflächenantigene und ihre Bedeutung für Serotypisierung und Vakzine. Hautarzt 36, 320–325 (1985)PubMedGoogle Scholar
  128. 128.
    Krause, W, Bleyl, A, Weidner, W, Schiefer, H G, Blechschmidt, J: Die Häufigkeit der postgonorrhoischen Urethritis ist nach Minocyclinbehandlung gegenüber Penicillin/Spectinomycin vermindert. Z. Hautkr. 61, 805–810 (1986)PubMedGoogle Scholar
  129. 129.
    Weidner, W, Schiefer, H G, Ebner, H, Brunner, H: Nongonococcal urethritis: leucocyte counts in urethral secretions correlated to chlamydial and ureaplasmal infections. Europ. J. sex. transmitt. Dis. 3,207–211 (1986)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1987

Authors and Affiliations

  • W. Krause
    • 1
  • W. Weidner
    • 1
  1. 1.Abt. Andrologie und Venerologie, Zentrum f. Dermatologie und Andrologie und Abt. Urologie, Zentrum f. Chirurgie, Anästhesiologie und UrologieKlinikum der Justus Liebig-Universität GießenGießenDeutschland

Personalised recommendations